Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma
Crossref DOI link: https://doi.org/10.1158/1078-0432.CCR-17-0263
Published Online: 2017-08-31
Published Print: 2017-09-01
Update policy: https://doi.org/10.1158/crossmark_policy
Sagawa, Morihiko
Ohguchi, Hiroto
Harada, Takeshi
Samur, Mehmet K.
Tai, Yu-Tzu
Munshi, Nikhil C.
Kizaki, Masahiro
Hideshima, Teru
Anderson, Kenneth C.
Funding for this research was provided by:
NIH (P50-100707)
NIH (R01-CA 050947)
NIH (R01-CA178264)
